Cadrenal Therapeutics, Inc.
New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Nov 14, 2024
Total Offering
$9,428,594
Amount Sold
$9,428,594
Investors
5
First Sale
Nov 1, 2024
Offering Details
- Type
- Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- Yes
Related Persons
| Name | Role |
|---|---|
| Quang Pham | Related Person |
| Matthew Szot | Related Person |
| Douglas W. Losordo | Related Person |
| Jeff Cole | Related Person |
| STEVEN ZELENKOFSKE | Related Person |
| GLYNN WILSON | Related Person |
| Robert Lisicki | Related Person |
| JOHN R. MURPHY | Related Person |
Company
SEC Filing
0001213900-24-097866
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free